I9
I93A.F Indorama Ventures PCL DRC
- Market cap
- EUR 3.34B
- P/E
- -
- P/B
- 0.92x
- ROE
- 5.3%
- Dividend yield
- 3.24%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is I93A.F undervalued?
Graham numberThe Graham number of Indorama Ventures PCL DRC cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Indorama Ventures PCL DRC fundamental analysis
No fundamental analysis for Indorama Ventures PCL DRC yet.
Indorama Ventures PCL DRC stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Indorama Ventures PCL DRC
Indorama Ventures Public Company Limited, together with its subsidiaries, manufactures and distributes petrochemical products in Thailand, the United States, Brazil, and internationally. It operates through four segments: Combined PET, Indovida, Indovinya, and Fibers. The Combined PET segment manufactures and distributes polyethylene terephthalate (PET) value chain comprising paraxylene, purified terephthalic acid, PET, and recycling; and specialty PET-related chemicals, suc…
Full company profileIndorama Ventures PCL DRC financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Indorama Ventures PCL DRC annual financial statements (THB; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 255B | 286B | 347B | 353B | 332B | 468B | 656B | 541B | 542B | 447B | 505B |
| Gross Profit | 36.4B | 45.4B | 57.9B | 43.3B | 43.7B | 85.0B | 114B | 65.4B | 75.3B | 49.8B | 78.8B |
| Operating Income | 15.3B | 19.5B | 29.2B | 9.04B | 4.56B | 37.6B | 51.1B | 7.35B | 13.8B | -68.9M | 23.4B |
| EBITDA | - | 35.8B | 48.7B | 28.6B | 29.7B | 63.8B | 76.3B | 29.5B | 22.2B | 33.0B | 53.5B |
| Net Income | 16.2B | 20.9B | 26.5B | 5.25B | 2.41B | 26.3B | 31.0B | -10.8B | -19.3B | -7.35B | 7.09B |
| EPS | - | 3.98 | 4.71 | 0.94 | 0.43 | 4.68 | 5.52 | -1.92 | -3.43 | -1.31 | 1.26 |
| Balance Sheet | |||||||||||
| Total Assets | 258B | 282B | 379B | 381B | 453B | 542B | 624B | 590B | 542B | 523B | 573B |
| Total Liabilities | 167B | 163B | 227B | 242B | 318B | 371B | 423B | 412B | 403B | 395B | 426B |
| Shareholders' Equity | 89.1B | 117B | 145B | 130B | 127B | 159B | 186B | 164B | 126B | 118B | 135B |
| Cash & Short-term Investments | 4.03B | 6.88B | 5.58B | 10.4B | 18.9B | 16.2B | 21.2B | 18.7B | 17.5B | 27.4B | 40.4B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 24.9B | 28.9B | 32.0B | 40.8B | 43.4B | 33.8B | 78.0B | 56.1B | 35.1B | 48.0B | 56.8B |
| Capital Expenditure | 13.5B | 19.8B | 16.4B | 16.7B | 16.8B | 20.0B | 25.6B | 27.7B | 17.6B | 19.8B | 13.7B |
| Free Cash Flow | - | 8.85B | 15.4B | 24.0B | 25.3B | 10.6B | 49.4B | 28.4B | 17.5B | 28.2B | 43.1B |
| Ratios | |||||||||||
| ROE | 18.2% | 17.8% | 18.3% | 4.0% | 1.9% | 16.6% | 16.7% | -6.6% | -15.3% | -6.3% | 5.3% |
| ROA | 6.3% | 7.4% | 7.0% | 1.4% | 0.5% | 4.9% | 5.0% | -1.8% | -3.6% | -1.4% | 1.2% |
| Net Profit Margin | 6.4% | 7.3% | 7.6% | 1.5% | 0.7% | 5.6% | 4.7% | -2.0% | -3.6% | -1.6% | 1.4% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Indorama Ventures PCL DRC dividends
- Dividend yield
- 3.24%
- Forward dividend
- 0.02 EUR
- Payout ratio
- -
- Ex-dividend date
- Aug 27, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | THB 3.93B | 0.70 | - |
| 2024 | THB 3.93B | 0.70 | - |
| 2023 | THB 7.30B | 1.30 | - |
| 2022 | THB 8.89B | 1.58 | 28.7% |
| 2021 | THB 5.94B | 1.06 | 22.6% |
| 2020 | THB 4.67B | 0.83 | 193.6% |
| 2019 | EUR 8.91B | 1.59 | 169.7% |
| 2018 | EUR 9.98B | 1.78 | 37.7% |
| 2017 | EUR 5.10B | 0.97 | 24.4% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Indorama Ventures PCL DRC
- Insiders 0.00%
- Institutions 4.89%
- Public & others 95.12%
- Shares outstanding 5.61B
- Free float 1.82B
Indorama Ventures PCL DRC company profile
- Company name
- Indorama Ventures PCL DRC
- Ticker
- I93A.F
- ISIN
- TH1027010R10
- Exchange
- Frankfurt Exchange
- Sector
- Basic Materials
- Industry
- Chemicals
- Fiscal year end
- December
- Address
- 75/102 Ocean Tower 2, Bangkok, Thailand, 10110
- Phone
- 66 2 661 6661
- Website
- indoramaventures.com
About Indorama Ventures PCL DRC
Indorama Ventures Public Company Limited, together with its subsidiaries, manufactures and distributes petrochemical products in Thailand, the United States, Brazil, and internationally. It operates through four segments: Combined PET, Indovida, Indovinya, and Fibers. The Combined PET segment manufactures and distributes polyethylene terephthalate (PET) value chain comprising paraxylene, purified terephthalic acid, PET, and recycling; and specialty PET-related chemicals, such as purified isophthalic acid and naphthalene dicarboxylate. The Indovida segment manufactures and distributes packaging. The Indovinya segment offers specialty chemical solutions including home and personal care, crop solutions, coatings, and energy and resources; supply ethylene oxide to the Combined PET business; and manufactures and distributes integrated downstream surfactants. The Fibers segment offers polyester, rayon, nylon, polypropylene, composites, and worsted wool fibers for the home, apparel, hygiene and medical, automotive, and industrial/technical markets. The company was formerly known as Beacon Global Limited and changed its name to Indorama Ventures Public Company Limited in March 2009. The company was incorporated in 1994 and is headquartered in Bangkok, Thailand. Indorama Ventures Public Company Limited is a subsidiary of Indorama Resources Ltd.
Indorama Ventures PCL DRC management
10- Mr. Aloke Lohia Ph.D.Vice Chairman & Group CEO · born 1959
- Mr. Sanjay AhujaChief Operations Officer & Executive Director · born 1969
- Ms. Suchitra LohiaExecutive Director & Deputy Group CEO · born 1965
- Mr. Yashovardhan LohiaExecutive President of Petchem Projects & Executive Director · born 1988
- Mr. Ashok JainChief Financial Officer
- Mr. Manoj Kumar SharmaHead of Accounting · born 1967
- Mr. Vikash JalanSenior Vice President of Business Reporting & Investor Relations
- Mr. Souvik Roy ChowdhuryHead of Corporate Compliance & Company Secretary · born 1966
- Mr. Richard W. JonesSenior VP of Corporate Communications & Sustainability
- Mr. Anil Kumar AilaniHead of Internal Control